Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22129587 | 1.00 | ALDH1A1 (0.42) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL893491 | 1.00 | ALDH1A1 (0.42) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL15353382 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL22129635 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL7203910 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL893629 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL9119956 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL789200 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL16551763 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL893497 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4417180-A2 | THERMO-ACTIVE COMPOSITE DENTAL COMPOSITION | VOCO GmbH (DE) | 2024-08-21 | — | — | EP | claimed |
| EP-3810064-B1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2024-05-29 | — | — | EP | claimed |
| US-11944692-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2024-04-02 | — | — | US | claimed |
| EP-3810064-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GmbH (DE) | 2021-04-28 | — | — | EP | claimed |
| WO-2019243339-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2019-12-26 | — | — | WO | claimed |
| US-20130081999-A1 | Bridged Macrocyclic Module Compositions | WHITEFORD JEFFERY A (US) | 2013-04-04 | — | — | US | claimed |
| EP-1657239-B1 | Chromene compound | TOKUYAMA CORP (JP) | 2010-08-11 | — | — | EP | claimed |
| US-20100152438-A1 | AMPHIPHILIC MOLECULAR MODULES AND CONSTRUCTS BASED THEREON | COVALENT PARTNERS LLC | 2010-06-17 | — | — | US | claimed |
| US-20080290034-A1 | Bridged macrocyclic module compositions | COVALENT PARTNERS LLC | 2008-11-27 | — | — | US | claimed |
| US-20060270846-A1 | Amphiphilic molecular modules and constructs based thereon | COVALENT PARTNERS, LLC (US) | 2006-11-30 | — | — | US | claimed |
| US-20060128680-A1 | Macrocyclic module compositions | KRIESEL JOSH | 2006-06-15 | — | — | US | claimed |
| EP-1667965-A2 | BRIDGED MACROCYCLIC MODULE COMPOSITIONS | Covalent Partners, LLC (US) | 2006-06-14 | — | — | EP | claimed |
| US-20050154199-A1 | Bridged macrocyclic module compositions | COVALENT PARTNERS LLC | 2005-07-14 | — | — | US | claimed |
| EP-1480635-A4 | MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS LLC (US) | 2005-06-29 | — | — | EP | claimed |
| WO-2005030711-A2 | BRIDGED MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS LLC (US) | 2005-04-07 | — | — | WO | claimed |
| EP-1480635-A2 | MACROCYCLIC MODULE COMPOSITIONS | Covalent Partners, LLC (US) | 2004-12-01 | — | — | EP | claimed |
| US-20040034223-A1 | Amphiphilic molecular modules and constructs based thereon | COVALENT PARTNERS, LLC. | 2004-02-19 | — | — | US | claimed |
| US-20030199688-A1 | Macrocyclic module compositions | COVALENT PARTNERS, LLC | 2003-10-23 | — | — | US | claimed |
| WO-2003066646-A2 | MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS, LLC (US) | 2003-08-14 | — | — | WO | claimed |
| WO-2026103730-A1 | DIAZAHETEROCYCLIC DERIVATIVE OF PYRIDOARYL GROUP HAVING KAPPA RECEPTOR ANTAGONISTIC ACTIVITY AND COMPOSITION THEREOF, AND USE | 江苏恩华药业股份有限公司 | 2026-05-21 | — | — | WO | disclosed |
| US-12441823-B2 | Resin composition for optical shaping | KURARAY NORITAKE DENTAL INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-12318459-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2025-06-03 | — | — | US | disclosed |
| CN-116217566-B | Anti-apoptosis protein BCL-2 inhibitor, pharmaceutical composition and application thereof | 杭州和正医药有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-115724799-B | Potassium channel regulator, composition and application | 纽欧申医药(上海)有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119505962-A | Self-initiated high-power high-energy liquid fuel and preparation method thereof | 中国人民解放军军事科学院系统工程研究院 | 2025-02-25 | — | — | CN | disclosed |
| US-12227511-B2 | Bicyclic compounds as kinase modulators, methods and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-02-18 | — | — | US | disclosed |
| CN-119193204-A | High-energy liquid fuel system containing transition metal organic complex and preparation method thereof | 中国人民解放军军事科学院系统工程研究院 | 2024-12-27 | — | — | CN | disclosed |
| CN-119192808-A | Resin composition | 味之素株式会社 | 2024-12-27 | — | — | CN | disclosed |
| CN-118598858-A | Multifunctional compound, composition and application of degradable BTK kinase | 杭州和正医药有限公司 | 2024-09-06 | — | — | CN | disclosed |
| US-20240293290-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2024-09-05 | — | — | US | disclosed |
| EP-4417180-A2 | THERMO-ACTIVE COMPOSITE DENTAL COMPOSITION | VOCO GmbH (DE) | 2024-08-21 | — | — | EP | disclosed |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | KURARAY CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| CN-116143757-B | Multifunctional compound, composition and application of degradable BTK kinase | 杭州和正医药有限公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-3810064-B1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2024-05-29 | — | — | EP | disclosed |
| CN-114072439-B | Curable composition and resin composition for photofabrication comprising same | 株式会社可乐丽 | 2024-05-14 | — | — | CN | disclosed |
| US-11944692-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2024-04-02 | — | — | US | disclosed |
| CN-113993497-B | Curable composition and resin composition for photofabrication comprising same | 株式会社可乐丽 | 2024-03-22 | — | — | CN | disclosed |
| EP-3900693-B1 | USE OF A RESIN COMPOSITION | KURARAY NORITAKE DENTAL INC (JP) | 2024-03-20 | — | — | EP | disclosed |
| US-20230391789-A1 | BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-12-07 | — | — | US | disclosed |
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | KURARAY CO., LTD. (JP) | 2023-11-14 | — | — | US | disclosed |
| US-11702425-B2 | Bicyclic compounds as kinase modulators, methods and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-07-18 | — | — | US | disclosed |
| US-20220325025-A1 | CURABLE COMPOSITION AND STEREOLITHOGRAPHIC RESIN COMPOSITION COMPRISING SAME | KURARAY CO., LTD. (JP) | 2022-10-13 | — | — | US | disclosed |
| US-20220242978-A1 | CURABLE COMPOSITION, AND RESIN COMPOSITION FOR STEREOLITHOGRAPHY PREPARED THEREFROM | KURARAY CO., LTD. (JP) | 2022-08-04 | — | — | US | disclosed |
| EP-3991958-A1 | CURABLE COMPOSITION AND STEREOLITHOGRAPHIC RESIN COMPOSITION COMPRISING SAME | Kuraray Co., Ltd. (JP) | 2022-05-04 | — | — | EP | disclosed |
| EP-3992216-A1 | CURABLE COMPOSITION, AND RESIN COMPOSITION FOR STEREOLITHOGRAPHY PREPARED THEREFROM | Kuraray Co., Ltd. (JP) | 2022-05-04 | — | — | EP | disclosed |
| CN-114072439-A | Curable composition and resin composition for stereolithography comprising same | 株式会社可乐丽 | 2022-02-18 | — | — | CN | disclosed |
| US-20220041777-A1 | RESIN COMPOSITION FOR OPTICAL SHAPING | KURARAY NORITAKE DENTAL INC. (JP) | 2022-02-10 | — | — | US | disclosed |
| CN-113993497-A | Curable composition and resin composition for stereolithography comprising same | 株式会社可乐丽 | 2022-01-28 | — | — | CN | disclosed |
| EP-3900693-A1 | RESIN COMPOSITION FOR OPTICAL MOLDING | Kuraray Noritake Dental Inc. (JP) | 2021-10-27 | — | — | EP | disclosed |
| US-20210309668-A1 | BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-10-07 | — | — | US | disclosed |
| EP-3810064-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GmbH (DE) | 2021-04-28 | — | — | EP | disclosed |
| WO-2020129736-A1 | RESIN COMPOSITION FOR OPTICAL MOLDING | クラレノリタケデンタル株式会社 | 2020-06-25 | — | — | WO | disclosed |
| WO-2020027723-A1 | BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-02-06 | — | — | WO | disclosed |
| WO-2019243339-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2019-12-26 | — | — | WO | disclosed |
| EP-2623086-B1 | Curable mixture comprising plasticisers with a polyalicyclic structure element for use in the production of dental materials. | VOCO GMBH (DE) | 2019-07-10 | — | — | EP | disclosed |
| US-9856219-B2 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2018-01-02 | — | — | US | disclosed |
| US-9814700-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents | NIVALIS THERAPEUTICS, INC. (US) | 2017-11-14 | — | — | US | disclosed |
| US-9707212-B2 | S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2017-07-18 | — | — | US | disclosed |
| US-20170049750-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | LAUREL THERAPEUTICS LTD. (CN) | 2017-02-23 | — | — | US | disclosed |
| US-20160340312-A1 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors | LAUREL THERAPEUTICS LTD. (CN) | 2016-11-24 | — | — | US | disclosed |
| US-9498466-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents | NIVALIS THERAPEUTICS, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| US-20160326157-A1 | MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-11-10 | — | — | US | disclosed |
| EP-2318006-B1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | NIVALIS THERAPEUTICS INC (US) | 2016-10-12 | — | — | EP | disclosed |
| US-20160279117-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, LLC | 2016-09-29 | — | — | US | disclosed |
| EP-3069721-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | Nivalis Therapeutics, Inc. (US) | 2016-09-21 | — | — | EP | disclosed |
| US-9433618-B2 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2016-09-06 | — | — | US | disclosed |
| CN-102869255-B | The novel inhibitors of GSNO reductase | 内瓦利斯治疗公司 | 2016-08-31 | — | — | CN | disclosed |
| US-20160220556-A1 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors | LAUREL THERAPEUTICS LTD. (CN) | 2016-08-04 | — | — | US | disclosed |
| US-9364481-B2 | Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2016-06-14 | — | — | US | disclosed |
| US-20160108011-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, LLC | 2016-04-21 | — | — | US | disclosed |
| US-9315462-B2 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2016-04-19 | — | — | US | disclosed |
| EP-2315591-B1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | NIVALIS THERAPEUTICS INC (US) | 2016-03-16 | — | — | EP | disclosed |
| US-9283229-B2 | Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2016-03-15 | — | — | US | disclosed |
| US-9283213-B2 | Dihydropyridin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists | NIVALIS THERAPEUTICS, INC. (US) | 2016-03-15 | — | — | US | disclosed |
| US-20160067254-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, LLC | 2016-03-10 | — | — | US | disclosed |
| US-20160045478-A1 | Novel S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, LLC | 2016-02-18 | — | — | US | disclosed |
| US-20160045477-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | LAUREL THERAPEUTICS LTD. (CN) | 2016-02-18 | — | — | US | disclosed |
| EP-2533638-B1 | NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | NIVALIS THERAPEUTICS INC (US) | 2016-02-10 | — | — | EP | disclosed |
| US-9249132-B2 | Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| EP-2977050-A1 | NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | Nivalis Therapeutics, Inc. (US) | 2016-01-27 | — | — | EP | disclosed |
| US-9221810-B2 | Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2015-12-29 | — | — | US | disclosed |
| US-20150336897-A1 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors | LAUREL THERAPEUTICS LTD. (CN) | 2015-11-26 | — | — | US | disclosed |
| US-9187447-B2 | S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2015-11-17 | — | — | US | disclosed |
| US-9180119-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents | NIVALIS THERAPEUTICS, INC. (US) | 2015-11-10 | — | — | US | disclosed |
| WO-2015143376-A1 | NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS | NIVALIS THERAPEUTICS, INC. (US) | 2015-09-24 | — | — | WO | disclosed |
| EP-2624695-B1 | NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | NIVALIS THERAPEUTICS INC (US) | 2015-09-23 | — | — | EP | disclosed |
| US-9138427-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents | NIVALIS THERAPEUTICS, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-9139528-B2 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| EP-2592934-B1 | NOVEL DIHYDROPYRIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS AND NEUROKININ-3 RECEPTOR ANTAGONISTS | NIVALIS THERAPEUTICS INC (US) | 2015-08-26 | — | — | EP | disclosed |
| US-20150224107-A1 | Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, LLC | 2015-08-13 | — | — | US | disclosed |
| US-9079828-B2 | Polymerizable compounds comprising a polyalicylic structure element | VOCO GMBH (DE) | 2015-07-14 | — | — | US | disclosed |
| WO-2015103583-A1 | MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-07-09 | — | — | WO | disclosed |
| US-20150183774-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, LLC | 2015-07-02 | — | — | US | disclosed |
| US-9067893-B2 | Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2015-06-30 | — | — | US | disclosed |
| US-20150157616-A1 | Novel Dihydropyridin-2(1H)-One Compounds as S-Nitrosoglutathione Reductase Inhibitors and Neurokinin-3 Receptor Antagonists | NIVALIS THERAPEUTICS, INC. | 2015-06-11 | — | — | US | disclosed |
| US-9029402-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase | NIVALIS THERAPEUTICS, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-20150126570-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | LAUREL THERAPEUTICS LTD. (CN) | 2015-05-07 | — | — | US | disclosed |
| US-9012646-B2 | Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors | NIVALIS THERAPEUTICS, INC. (US) | 2015-04-21 | — | — | US | disclosed |
| US-20150080429-A1 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors | LAUREL THERAPEUTICS LTD. (CN) | 2015-03-19 | — | — | US | disclosed |
| US-8957105-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents | N30 PHARMACEUTICALS, INC. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8946434-B2 | Dihydropyridin-2(1H)-one compound as S-nirtosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists | N30 PHARMACEUTICALS, INC. (US) | 2015-02-03 | — | — | US | disclosed |
| US-8921562-B2 | Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors | N30 PHARMACEUTICALS, INC. (US) | 2014-12-30 | — | — | US | disclosed |
| US-8906933-B2 | Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists | N30 PHARMACEUTICALS, INC. (US) | 2014-12-09 | — | — | US | disclosed |
| WO-2014186704-A2 | NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS | N30 PHARMACEUTICALS, INC. (US) | 2014-11-20 | — | — | WO | disclosed |
| US-20140329821-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | NIVALIS THERAPEUTICS, INC. | 2014-11-06 | — | — | US | disclosed |
| US-8859611-B2 | Thiophene inhibitors of S-nitrosoglutathione reductase | N30 PHARMACEUTICALS, INC. (US) | 2014-10-14 | — | — | US | disclosed |
| US-8846736-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents | N30 PHARMACEUTICALS, INC. (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140275185-A1 | Novel S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140235640-A1 | Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, INC. (US) | 2014-08-21 | — | — | US | disclosed |
| US-8785643-B2 | Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors | N30 PHARMACEUTICALS, INC. (US) | 2014-07-22 | — | — | US | disclosed |
| US-20140194481-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | N30 PHARMACEUTICALS, INC. (US) | 2014-07-10 | — | — | US | disclosed |
| US-20140194425-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | N30 PHARMACEUTICALS, INC. (US) | 2014-07-10 | — | — | US | disclosed |
| US-8759548-B2 | S-nitrosoglutathione reductase inhibitors | N30 PHARMACEUTICALS, INC. (US) | 2014-06-24 | — | — | US | disclosed |
| US-20140155447-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | N30 PHARMACEUTICALS, INC. (US) | 2014-06-05 | — | — | US | disclosed |
| EP-2512247-B1 | NOVEL THIOPHENE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE | N30 PHARMACEUTICALS INC (US) | 2014-06-04 | — | — | EP | disclosed |
| US-8741915-B2 | Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors | N30 PHARMACEUTICALS, INC. (US) | 2014-06-03 | — | — | US | disclosed |
| US-20140113945-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents for Liver Toxicity | N30 PHARMACEUTICALS, INC. (US) | 2014-04-24 | — | — | US | disclosed |
| US-20140113938-A1 | Pyrrole Inhibitors of S-Nitrosoglutathione Reductase | NIVALIS THERAPEUTICS, INC. | 2014-04-24 | — | — | US | disclosed |
| US-8697772-B2 | Polymerizable phosphoric acid derivatives comprising a polyalicylic structure element | VOCO GMBH (DE) | 2014-04-15 | — | — | US | disclosed |
| US-8673961-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents | N30 PHARMACEUTICALS, INC. (US) | 2014-03-18 | — | — | US | disclosed |
| US-20140057957-A1 | Novel Thiophene Inhibitors of S-Nitrosoglutathione Reductase | N30 PHARMACEUTICALS, INC. (US) | 2014-02-27 | — | — | US | disclosed |
| US-8642628-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase | N30 PHARMACEUTICALS, INC. (US) | 2014-02-04 | — | — | US | disclosed |
| US-8618023-B2 | Microbiocides | SYNGENTA CROP PROTECTION, LLC (US) | 2013-12-31 | — | — | US | disclosed |
| US-20130345432-A1 | ASYMMETRIC PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES | AMGEN INC. (US) | 2013-12-26 | — | — | US | disclosed |
| US-20130331261-A1 | PYRAZOLE CARBOXYLIC ACID AMIDES USEFUL FOR THE REDUCTION OF MYCOTOXIN CONTAMINATION IN PLANTS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-12-12 | — | — | US | disclosed |
| US-8586624-B2 | Thiophene inhibitors of S-nitrosoglutathione reductase | N30 PHARMACEUTICALS, INC. (US) | 2013-11-19 | — | — | US | disclosed |
| US-8580843-B2 | Use of diindolylmethane (DIM) compounds and derivatives as neuroprotective agents | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2013-11-12 | — | — | US | disclosed |
| EP-2651871-A1 | NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 Pharmaceuticals, Inc. (US) | 2013-10-23 | — | — | EP | disclosed |
| EP-2651223-A1 | NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 Pharmaceuticals, Inc. (US) | 2013-10-23 | — | — | EP | disclosed |
| US-20130261123-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | NIVALIS THERAPEUTICS, INC. | 2013-10-03 | — | — | US | disclosed |
| US-20130261122-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | N30 Pharmaceuticls, Inc. (US) | 2013-10-03 | — | — | US | disclosed |
| CN-102186478-B | Pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents | N30 PHARMACEUTICALS LLC | 2013-10-02 | — | — | CN | disclosed |
| US-20130253024-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | N30 PHARMACEUTICALS, INC. (US) | 2013-09-26 | — | — | US | disclosed |
| EP-2624695-A1 | NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 Pharmaceuticals, Inc. (US) | 2013-08-14 | — | — | EP | disclosed |
| EP-2623086-A2 | Curable mixture comprising plasticisers with a polyalicyclic structure element for use in the production of dental materials. | VOCO GmbH (DE) | 2013-08-07 | — | — | EP | disclosed |
| US-8501954-B2 | Asymmetric process for making substituted 2-amino-thiazolones | AMGEN INC. (US) | 2013-08-06 | — | — | US | disclosed |
| EP-2618666-A1 | NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS | N30 Pharmaceuticals, Inc. (US) | 2013-07-31 | — | — | EP | disclosed |
| EP-2155686-B1 | PYRAZOLE CARBOXYLIC ACID AMIDES USEFUL AS MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2013-07-17 | — | — | EP | disclosed |
| US-20130178499-A1 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, INC. (US) | 2013-07-11 | — | — | US | disclosed |
| US-8470857-B2 | Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents | N30 PHARMACEUTICALS, INC. (US) | 2013-06-25 | — | — | US | disclosed |
| US-20130131093-A1 | Novel Dihydropyrimidin-2(1H)-One Compounds As Neurokinin-3 Receptor Antagonists | N30 PHARMACEUTICALS, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| EP-2592934-A1 | NOVEL DIHYDROPYRIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS AND NEUROKININ-3 RECEPTOR ANTAGONISTS | N30 Pharmaceuticals, Inc. (US) | 2013-05-22 | — | — | EP | disclosed |
| US-20130096161-A1 | Novel Dihydropyridin-2(1H)-One Compounds as S-Nitrosoglutathione Reductase Inhibitors and Neurokinin-3 Receptor Antagonists | N30 PHARMACEUTICALS, INC. (US) | 2013-04-18 | — | — | US | disclosed |
| US-8415166-B2 | Semiconductor detector for peroxide-based explosives | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2013-04-09 | — | — | US | disclosed |
| US-20130081999-A1 | Bridged Macrocyclic Module Compositions | WHITEFORD JEFFERY A (US) | 2013-04-04 | — | — | US | disclosed |
| EP-2318007-B1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 PHARMACEUTICALS INC (US) | 2013-01-23 | — | — | EP | disclosed |
| WO-2013006635-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS FOR LIVER TOXICITY | N30 PHARMACEUTICALS, LLC (US) | 2013-01-10 | — | — | WO | disclosed |
| EP-2533638-A1 | NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 Pharmaceuticals, Inc. (US) | 2012-12-19 | — | — | EP | disclosed |
| WO-2012170371-A1 | COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 PHARMACEUTICALS, LLC (US) | 2012-12-13 | — | — | WO | disclosed |
| US-20120289555-A1 | Novel S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, LLC (US) | 2012-11-15 | — | — | US | disclosed |
| US-8304444-B2 | Pyrazole carboxylic acid amides useful as microbiocides | SYNGENTA CROP PROTECTION, LLC (US) | 2012-11-06 | — | — | US | disclosed |
| EP-2512247-A1 | NOVEL THIOPHENE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE | N30 Pharmaceuticals, LLC (US) | 2012-10-24 | — | — | EP | disclosed |
| US-20120245210-A1 | Novel Thiophene Inhibitors of S-Nitrosoglutathione Reductase | N30 PHARMACEUTICALS, LLC (US) | 2012-09-27 | — | — | US | disclosed |
| EP-2315590-B1 | PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE | N30 PHARMACEUTICALS LLC (US) | 2012-09-26 | — | — | EP | disclosed |
| EP-2029530-B1 | ETHENYL CARBOXAMIDE DERIVATIVES USEFUL AS MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2012-09-19 | — | — | EP | disclosed |
| EP-2436668-B1 | Polymerisable compounds comprising a polyalicyclic structure element | VOCO GMBH (DE) | 2012-09-12 | — | — | EP | disclosed |
| US-20120208817-A1 | Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors | N30 PHARMACEUTICALS, LLC (US) | 2012-08-16 | — | — | US | disclosed |
| EP-2480086-A1 | NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 Pharmaceuticals, LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| WO-2012083165-A1 | NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 PHARMACEUTICALS, LLC (US) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012083171-A1 | NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 PHARMACEUTICALS, LLC (US) | 2012-06-21 | — | — | WO | disclosed |
| EP-2321290-B1 | ASYMMETRIC PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES | AMGEN INC (US) | 2012-06-20 | — | — | EP | disclosed |
| US-8188088-B2 | Ethenyl carboxamide derivatives useful as microbiocides | SYNGENTA PARTICIPATIONS AG (CH) | 2012-05-29 | — | — | US | disclosed |
| US-8182695-B2 | Bridged macrocyclic module compositions | WHITEFORD JEFFERY A (US) | 2012-05-22 | — | — | US | disclosed |
| US-20120115108-A1 | POLYMERIZABLE PHOSPHORIC ACID DERIVATIVES COMPRISING A POLYALICYLIC STRUCTURE ELEMENT | VOCO GMBH (DE) | 2012-05-10 | — | — | US | disclosed |
| EP-2450025-A1 | Polymerisable phosphoric acid derivatives comprising a polyalicyclic structure element | VOCO GmbH (DE) | 2012-05-09 | — | — | EP | disclosed |
| WO-2012048181-A1 | NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 PHARMACEUTICALS, LLC (US) | 2012-04-12 | — | — | WO | disclosed |
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | VOCO GMBH (DE) | 2012-04-05 | — | — | US | disclosed |
| EP-2436668-A1 | Polymerisable compounds comprising a polyalicyclic structure element | VOCO GmbH (DE) | 2012-04-04 | — | — | EP | disclosed |
| WO-2012039718-A1 | NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS | N30 PHARMACEUTICALS, LLC (US) | 2012-03-29 | — | — | WO | disclosed |
| US-8110679-B2 | Nanofilm and membrane compositions | COVALENT PARTNERS LLC (US) | 2012-02-07 | — | — | US | disclosed |
| WO-2012009227-A1 | NOVEL DIHYDROPYRIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS AND NEUROKININ-3 RECEPTOR ANTAGONISTS | N30 PHARMACEUTICALS, LLC (US) | 2012-01-19 | — | — | WO | disclosed |
| CN-102186478-A | Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents | N30 PHARMACEUTICALS LLC | 2011-09-14 | — | — | CN | disclosed |
| US-20110207771-A1 | N-(L-ALKYL-2-PHENYLETHYL)-CARBOXAMIDE DERIVATIVES AND USE THEREOF AS FUNGICIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2011-08-25 | — | — | US | disclosed |
| WO-2011100433-A1 | NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 PHARMACEUTICALS, LLC (US) | 2011-08-18 | — | — | WO | disclosed |
| US-20110178307-A1 | ASYMMETRIC PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES | AMGEN INC. (US) | 2011-07-21 | — | — | US | disclosed |
| WO-2011075478-A1 | NOVEL THIOPHENE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE | N30 PHARMACEUTICALS, LLC (US) | 2011-06-23 | — | — | WO | disclosed |
| US-20110144180-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | N30 PHARMACEUTICALS, LLC (US) | 2011-06-16 | — | — | US | disclosed |
| US-20110144110-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | N30 PHARMACEUTICALS, LLC (US) | 2011-06-16 | — | — | US | disclosed |
| US-20110136875-A1 | Pyrrole Inhibitors of S-Nitrosoglutathione Reductase | N30 PHARMACEUTICALS, LLC (US) | 2011-06-09 | — | — | US | disclosed |
| US-20110136881-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | N30 PHARMACEUTICALS, LLC (US) | 2011-06-09 | — | — | US | disclosed |
| US-20110129937-A1 | SEMICONDUCTOR DETECTOR FOR PEROXIDE-BASED EXPLOSIVES | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2011-06-02 | — | — | US | disclosed |
| EP-2321290-A1 | ASYMMETRIC PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES | Amgen, Inc (US) | 2011-05-18 | — | — | EP | disclosed |
| EP-2318007-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 Pharmaceuticals, LLC (US) | 2011-05-11 | — | — | EP | disclosed |
| EP-2318006-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 Pharmaceuticals, LLC (US) | 2011-05-11 | — | — | EP | disclosed |
| EP-2315590-A1 | PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE | N30 Pharmaceuticals, LLC (US) | 2011-05-04 | — | — | EP | disclosed |
| EP-2315591-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 Pharmaceuticals, LLC (US) | 2011-05-04 | — | — | EP | disclosed |
| EP-2307883-A2 | DETECTOR FOR PEROXIDE-BASED EXPLOSIVES | Yeda Research And Development Company Ltd. (IL) | 2011-04-13 | — | — | EP | disclosed |
| WO-2011038204-A1 | NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 PHARMACEUTICALS, LLC (US) | 2011-03-31 | — | — | WO | disclosed |
| EP-1657239-B1 | Chromene compound | TOKUYAMA CORP (JP) | 2010-08-11 | — | — | EP | disclosed |
| US-7767810-B2 | Macrocyclic modules comprising linked cyclic synthon units for use in the formation of selectively permeable membranes | COVALENT PARTNERS, LLC (US) | 2010-08-03 | — | — | US | disclosed |
| US-20100173966-A1 | PYRAZOLE CARBOXYLIC ACID AMIDES USEFUL AS MICROBIOCIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2010-07-08 | — | — | US | disclosed |
| US-20100152438-A1 | AMPHIPHILIC MOLECULAR MODULES AND CONSTRUCTS BASED THEREON | COVALENT PARTNERS LLC | 2010-06-17 | — | — | US | disclosed |
| WO-2010042657-A1 | USE OF DIINDOLYLMETHANE (DIM) COMPOUNDS AND DERIVATIVES AS NEUROPROTECTIVE AGENTS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-04-15 | — | — | WO | disclosed |
| US-20100087504-A1 | Use of Diindolylmethane (DIM) Compounds and Derivatives as Neuroprotective Agents | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-04-08 | — | — | US | disclosed |
| EP-1655293-B1 | Chromene compound and articles comprising the same | TOKUYAMA CORP (JP) | 2010-03-31 | — | — | EP | disclosed |
| EP-2155686-A1 | PYRAZOLE CARBOXYLIC ACID AMIDES USEFUL AS MICROBIOCIDES | Syngeta Participations AG (CH) | 2010-02-24 | — | — | EP | disclosed |
| WO-2010019905-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 PHARMACEUTICALS, LLC (US) | 2010-02-18 | — | — | WO | disclosed |
| WO-2010019909-A1 | PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE | N30 PHARMACEUTICALS, LLC (US) | 2010-02-18 | — | — | WO | disclosed |
| WO-2010019903-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 PHARMACEUTICALS, LLC (US) | 2010-02-18 | — | — | WO | disclosed |
| WO-2010019910-A1 | NOVEL PYRROLE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE AS THERAPEUTIC AGENTS | N30 PHARMACEUTICALS, LLC (US) | 2010-02-18 | — | — | WO | disclosed |
| WO-2010014586-A1 | ASYMMETRIC PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES | AMGEN INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| US-20100022570-A1 | NOVEL MICROBIOCIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2010-01-28 | — | — | US | disclosed |
| WO-2010010547-A2 | DETECTOR FOR PEROXIDE-BASED EXPLOSIVES | YEDA RESEARCH AND DEVELOPMENT CO. LTD (IL) | 2010-01-28 | — | — | WO | disclosed |
| US-7652059-B2 | 1-methyl-4-trifluoromethyl-1H-pyrrole-3-carboxylic acid [2-(1,3-dimethylbutyl)phenyl]amide; protecting plants against infestation by phytopathogenic microorganisms | SYNGENTA CROP PROTECTION, INC. (US) | 2010-01-26 | — | — | US | disclosed |
| US-20090318495-A1 | ETHENYL CARBOXAMIDE DERIVATIVES USEFUL AS MICROBIOCIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2009-12-24 | — | — | US | disclosed |
| EP-2018367-B1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2009-11-18 | — | — | EP | disclosed |
| US-7595368-B2 | Nanofilm compositions with polymeric components | COVALENT PARTNERS, LLC (US) | 2009-09-29 | — | — | US | disclosed |
| US-7563890-B2 | Amphiphilic molecular modules and constructs based thereon | COVALENT PARTNERS, LLC (US) | 2009-07-21 | — | — | US | disclosed |
| US-20090114596-A1 | NANOFILM AND MEMBRANE COMPOSITIONS | COVALENT PARTNERS LLC | 2009-05-07 | — | — | US | disclosed |
| EP-2035374-A1 | N- (L-ALKYL-2- PHENYLETHYL) -CARBOXAMIDE DERIVATIVES AND USE THEREOF AS FUNGICIDES | Syngeta Participations AG (CH) | 2009-03-18 | — | — | EP | disclosed |
| EP-2029530-A1 | ETHENYL CARBOXAMIDE DERIVATIVES USEFUL AS MICROBIOCIDES | Syngeta Participations AG (CH) | 2009-03-04 | — | — | EP | disclosed |
| WO-2009023201-A1 | RIGID DERIVATIVES OF TRIPTOLIDE AS ANTICANCER, IMMUNE SUPPRESSANT, ANTI-FIBROSIS, AND CNS PROTECTANT AGENTS | MYELORX LLC (US) | 2009-02-19 | — | — | WO | disclosed |
| EP-2018367-A1 | NOVEL MICROBIOCIDES | Syngeta Participations AG (CH) | 2009-01-28 | — | — | EP | disclosed |
| WO-2008148570-A1 | PYRAZOLE CARBOXYLIC ACID AMIDES USEFUL AS MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2008-12-11 | — | — | WO | disclosed |
| US-20080290034-A1 | Bridged macrocyclic module compositions | COVALENT PARTNERS LLC | 2008-11-27 | — | — | US | disclosed |
| US-7432371-B2 | Nanofilm and membrane compositions | COVALENT PARTNERS, LLC (US) | 2008-10-07 | — | — | US | disclosed |
| US-7368564-B2 | Bridged macrocyclic module compositions | COVALENT PARTNERS, LLC (US) | 2008-05-06 | — | — | US | disclosed |
| WO-2007144174-A1 | ETHENYL CARBOXAMIDE DERIVATIVES USEFUL AS MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007141009-A1 | N- (L-ALKYL-2- PHENYLETHYL) -CARBOXAMIDE DERIVATIVES AND USE THEREOF AS FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2007-12-13 | — | — | WO | disclosed |
| WO-2007134799-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2007-11-29 | — | — | WO | disclosed |
| US-7295749-B2 | Curable resin composition, optical component and optical waveguide | OMRON CORPORATION (JP) | 2007-11-13 | — | — | US | disclosed |
| EP-1630180-B1 | CURING RESIN COMPOSITION, OPTICAL COMPONENT AND OPTICAL WAVEGUIDE | OMRON TATEISI ELECTRONICS CO (JP) | 2007-02-07 | — | — | EP | disclosed |
| US-20070025679-A1 | Curable resin composition, optical component and optical waveguide | OMRON CORPORATION (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20060270846-A1 | Amphiphilic molecular modules and constructs based thereon | COVALENT PARTNERS, LLC (US) | 2006-11-30 | — | — | US | disclosed |
| EP-1341757-B1 | PYRROLCARBOXAMIDES AND PYRROLCARBOTHIOAMIDES AND THEIR AGROCHEMICAL USES | SYNGENTA PARTICIPATIONS AG (CH) | 2006-09-20 | — | — | EP | disclosed |
| US-7105565-B2 | Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses | SYNGENTA CROP PROTECTION, INC. (US) | 2006-09-12 | — | — | US | disclosed |
| US-20060189676-A1 | Pyrrolcarboxamides and Pyrrolcarbothioamides | SYNGENTA CROP PROTECTION, INC. (US) | 2006-08-24 | — | — | US | disclosed |
| EP-1394156-B1 | CHROMENE COMPOUND | TOKUYAMA CORP (JP) | 2006-07-12 | — | — | EP | disclosed |
| US-20060128680-A1 | Macrocyclic module compositions | KRIESEL JOSH | 2006-06-15 | — | — | US | disclosed |
| EP-1667965-A2 | BRIDGED MACROCYCLIC MODULE COMPOSITIONS | Covalent Partners, LLC (US) | 2006-06-14 | — | — | EP | disclosed |
| US-7048876-B2 | Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm. | TOKUYAMA CORPORATION (JP) | 2006-05-23 | — | — | US | disclosed |
| EP-1657239-A2 | Chromene compound | Tokuyama Corporation (JP) | 2006-05-17 | — | — | EP | disclosed |
| EP-1655293-A2 | Chromene compound | Tokuyama Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| EP-1655294-A2 | Chromene compound | Tokuyama Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| EP-1630180-A1 | CURING RESIN COMPOSITION, OPTICAL COMPONENT AND OPTICAL WAVEGUIDE | Omron Corporation (JP) | 2006-03-01 | — | — | EP | disclosed |
| US-20060041077-A1 | Nanofilm compositions with polymeric components | COVALENT PARTNERS LLC | 2006-02-23 | — | — | US | disclosed |
| EP-1573833-A2 | NANOFILM COMPOSITIONS WITH POLYMERIC COMPONENTS | Covalent Partners, LLC (US) | 2005-09-14 | — | — | EP | disclosed |
| US-20050154199-A1 | Bridged macrocyclic module compositions | COVALENT PARTNERS LLC | 2005-07-14 | — | — | US | disclosed |
| EP-1480635-A4 | MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS LLC (US) | 2005-06-29 | — | — | EP | disclosed |
| EP-1481268-A4 | NANOFILM AND MEMBRANE COMPOSITIONS | COVALENT PARTNERS LLC (US) | 2005-06-29 | — | — | EP | disclosed |
| US-20050119130-A1 | Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses | SYNGENTA CROP PROTECTION, INC. | 2005-06-02 | — | — | US | disclosed |
| US-20050112409-A1 | Magnetic recording medium | FUJI PHOTO FILM CO., LTD. | 2005-05-26 | — | — | US | disclosed |
| WO-2005030711-A2 | BRIDGED MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS LLC (US) | 2005-04-07 | — | — | WO | disclosed |
| WO-2005018013-A2 | NANOFILM COMPOSITIONS WITH POLYMERIC COMPONENTS | COVALENT PARTNERS, LLC (US) | 2005-02-24 | — | — | WO | disclosed |
| US-20040260085-A1 | Nanofilm and membrane compositions | COVALENT PARTNERS LLC | 2004-12-23 | — | — | US | disclosed |
| EP-1481268-A2 | NANOFILM AND MEMBRANE COMPOSITIONS | Covalent Partners, LLC (US) | 2004-12-01 | — | — | EP | disclosed |
| EP-1480635-A2 | MACROCYCLIC MODULE COMPOSITIONS | Covalent Partners, LLC (US) | 2004-12-01 | — | — | EP | disclosed |
| US-20040106741-A1 | Nanofilm compositions with polymeric components | COVALENT PARTNERS LLC | 2004-06-03 | — | — | US | disclosed |
| US-20040094753-A1 | Chromene compound | TOKUYAMA CORPORATION (JP) | 2004-05-20 | — | — | US | disclosed |
| US-6723859-B2 | BASE STRUCTURE IS A CHROMENE(3,2-A)FLUORENE RING CONTAINING SPIRO-FUSED RINGS; PHOTOCHROMIC LENSES; LARGE FADING RATE, LESS COLOR WHEN DETERIORATED, AND EXCELLENT LIGHT RESISTANCE IN THE PHOTOCHROMIC PROPERTIES | TOKUYAMA CORPORATION (JP) | 2004-04-20 | — | — | US | disclosed |
| EP-1394156-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2004-03-03 | — | — | EP | disclosed |
| US-20040034223-A1 | Amphiphilic molecular modules and constructs based thereon | COVALENT PARTNERS, LLC. | 2004-02-19 | — | — | US | disclosed |
| US-20040014995-A1 | Chromene compounds | KAWABATA YUICHIRO (JP) | 2004-01-22 | — | — | US | disclosed |
| US-20030199688-A1 | Macrocyclic module compositions | COVALENT PARTNERS, LLC | 2003-10-23 | — | — | US | disclosed |
| EP-1341757-A1 | PYRROLCARBOXAMIDES AND PYRROLCARBOTHIOAMIDES AND THEIR AGROCHEMICAL USES | Syngenta Participations AG (CH) | 2003-09-10 | — | — | EP | disclosed |
| WO-2003067286-A2 | NANOFILM AND MEMBRANE COMPOSITIONS | COVALENT PARTNERS, LLC (US) | 2003-08-14 | — | — | WO | disclosed |
| WO-2003066646-A2 | MACROCYCLIC MODULE COMPOSITIONS | COVALENT PARTNERS, LLC (US) | 2003-08-14 | — | — | WO | disclosed |
| US-20030096117-A1 | Chromene compound | TOKUYAMA CORPORATION (JP) | 2003-05-22 | — | — | US | disclosed |
| WO-2002038542-A1 | PYRROLCARBOXAMIDES AND PYRROLCARBOTHIOAMIDES AND THEIR AGROCHEMICAL USES | SYNGENTA PARTICIPATIONS AG (CH) | 2002-05-16 | — | — | WO | disclosed |
| EP-1184379-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2002-03-06 | — | — | EP | disclosed |
| EP-1184379-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2002-03-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | WASF2, COPE, ARCN1 | ALDH1A1 2089/4885THRB 4400/4885MEN1 3152/4885 |
| US-20240293290-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | PUF60, POLQ, F10 | ALDH1A1 1414/4885THRB 4503/4885MEN1 1542/4885 |
| US-20140235640-A1 | Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors | QDPR, GSR, CBR1 | ALDH1A1 207/4885THRB 2394/4885MEN1 3816/4885 |
| US-20160340312-A1 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors | GSR, POR, CBR1 | ALDH1A1 290/4885THRB 2524/4885MEN1 4208/4885 |
| US-20160326157-A1 | MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE | MGAM, BPGM, MRPL21 | ALDH1A1 1587/4885THRB 2698/4885MEN1 230/4885 |
| US-20160279117-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | GSR, CBR1, POR | ALDH1A1 329/4885THRB 1767/4885MEN1 4669/4885 |
| US-20130178499-A1 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors | GSR, POR, CBR1 | ALDH1A1 290/4885THRB 2524/4885MEN1 4208/4885 |
| US-20220242978-A1 | CURABLE COMPOSITION, AND RESIN COMPOSITION FOR STEREOLITHOGRAPHY PREPARED THEREFROM | WASF2, COPE, ARCN1 | ALDH1A1 2089/4885THRB 4400/4885MEN1 3152/4885 |
| US-20130096161-A1 | Novel Dihydropyridin-2(1H)-One Compounds as S-Nitrosoglutathione Reductase Inhibitors and Neurokinin-3 Receptor Antagonists | QDPR, TACR1, TACR2 | ALDH1A1 751/4885THRB 1636/4885MEN1 2258/4885 |
| US-20160045477-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | GSR, DHFR, GRHPR | ALDH1A1 449/4885THRB 2088/4885MEN1 4582/4885 |
| US-20150157616-A1 | Novel Dihydropyridin-2(1H)-One Compounds as S-Nitrosoglutathione Reductase Inhibitors and Neurokinin-3 Receptor Antagonists | QDPR, TACR1, TACR2 | ALDH1A1 751/4885THRB 1636/4885MEN1 2258/4885 |
| US-20120208817-A1 | Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors | QDPR, GSR, CBR1 | ALDH1A1 207/4885THRB 2394/4885MEN1 3816/4885 |
| US-20030199688-A1 | Macrocyclic module compositions | CYCS, IMMT, INTS9 | ALDH1A1 4880/4885THRB 4845/4885MEN1 204/4885 |
| US-11702425-B2 | Bicyclic compounds as kinase modulators, methods and uses thereof | HCCS, PRKAA1, PRKAA2 | ALDH1A1 1942/4885THRB 1160/4885MEN1 4398/4885 |
| US-20110178307-A1 | ASYMMETRIC PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES | HSD11B1, HSD17B1, HSD17B2 | ALDH1A1 93/4885THRB 967/4885MEN1 1636/4885 |
| US-20150336897-A1 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors | GSR, POR, CBR1 | ALDH1A1 290/4885THRB 2524/4885MEN1 4208/4885 |
| US-20100152438-A1 | AMPHIPHILIC MOLECULAR MODULES AND CONSTRUCTS BASED THEREON | ANXA6, THEM6, ANXA5 | ALDH1A1 4330/4885THRB 4639/4885MEN1 1323/4885 |
| US-20120289555-A1 | Novel S-Nitrosoglutathione Reductase Inhibitors | GSR, GRHPR, POR | ALDH1A1 344/4885THRB 2072/4885MEN1 4332/4885 |
| US-12318459-B2 | Thermoactive dental composite composition | PUF60, POLQ, F10 | ALDH1A1 1414/4885THRB 4503/4885MEN1 1542/4885 |
| US-20150224107-A1 | Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors | QDPR, GSR, CBR1 | ALDH1A1 207/4885THRB 2394/4885MEN1 3816/4885 |
| US-20130253024-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | GSR, DHFR, GRHPR | ALDH1A1 449/4885THRB 2088/4885MEN1 4582/4885 |
| US-20230391789-A1 | BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF | HCCS, PRKAA1, PRKAA2 | ALDH1A1 1942/4885THRB 1160/4885MEN1 4398/4885 |
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | PCBP1, PUF60, PARG | ALDH1A1 3882/4885THRB 4037/4885MEN1 3381/4885 |
| US-20170049750-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | GSR, DHFR, GRHPR | ALDH1A1 449/4885THRB 2088/4885MEN1 4582/4885 |
| US-20160045478-A1 | Novel S-Nitrosoglutathione Reductase Inhibitors | GSR, GRHPR, POR | ALDH1A1 344/4885THRB 2072/4885MEN1 4332/4885 |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | ARL1, ASH2L, VCL | ALDH1A1 1097/4885THRB 3773/4885MEN1 2530/4885 |
| US-20040014995-A1 | Chromene compounds | SMARCE1, SMARCB1, SMARCA2 | ALDH1A1 2905/4885THRB 4750/4885MEN1 2481/4885 |
| US-20050119130-A1 | Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses | CBR3, PYCR1, CBR1 | ALDH1A1 3130/4885THRB 2820/4885MEN1 1736/4885 |
| US-20140275185-A1 | Novel S-Nitrosoglutathione Reductase Inhibitors | GSR, GRHPR, POR | ALDH1A1 344/4885THRB 2072/4885MEN1 4332/4885 |
| US-12227511-B2 | Bicyclic compounds as kinase modulators, methods and uses thereof | HCCS, PRKAA1, PRKAA2 | ALDH1A1 1942/4885THRB 1160/4885MEN1 4398/4885 |
| US-20100022570-A1 | NOVEL MICROBIOCIDES | QSOX1, MSR1, NOX1 | ALDH1A1 740/4885THRB 4358/4885MEN1 4016/4885 |
| US-20050154199-A1 | Bridged macrocyclic module compositions | SBDS, NCL, INTS6 | ALDH1A1 3961/4885THRB 4874/4885MEN1 1223/4885 |
| US-20210309668-A1 | BICYCLIC COMPOUNDS AS KINASE MODULATORS, METHODS AND USES THEREOF | HCCS, PRKAA1, PRKAA2 | ALDH1A1 1942/4885THRB 1160/4885MEN1 4398/4885 |
| US-20150080429-A1 | Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors | GSR, POR, CBR1 | ALDH1A1 290/4885THRB 2524/4885MEN1 4208/4885 |
| US-20140194425-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | GSR, DHFR, GRHPR | ALDH1A1 449/4885THRB 2088/4885MEN1 4582/4885 |
| US-20130131093-A1 | Novel Dihydropyrimidin-2(1H)-One Compounds As Neurokinin-3 Receptor Antagonists | TAC3, TACR2, TACR3 | ALDH1A1 3061/4885THRB 1815/4885MEN1 790/4885 |
| US-20060128680-A1 | Macrocyclic module compositions | CYCS, IMMT, INTS9 | ALDH1A1 4880/4885THRB 4845/4885MEN1 204/4885 |
| US-20100173966-A1 | PYRAZOLE CARBOXYLIC ACID AMIDES USEFUL AS MICROBIOCIDES | ARG1, FPR1, ARG2 | ALDH1A1 202/4885THRB 4220/4885MEN1 3573/4885 |
| US-20110207771-A1 | N-(L-ALKYL-2-PHENYLETHYL)-CARBOXAMIDE DERIVATIVES AND USE THEREOF AS FUNGICIDES | CYP1A1, CYP51A1, CYP2E1 | ALDH1A1 190/4885THRB 3456/4885MEN1 1701/4885 |
| US-20150183774-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | GSR, CBR1, POR | ALDH1A1 329/4885THRB 1767/4885MEN1 4669/4885 |
| US-20140155447-A1 | Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents | GSR, DHFR, GRHPR | ALDH1A1 449/4885THRB 2088/4885MEN1 4582/4885 |
| US-20130331261-A1 | PYRAZOLE CARBOXYLIC ACID AMIDES USEFUL FOR THE REDUCTION OF MYCOTOXIN CONTAMINATION IN PLANTS | AADAC, QPCT, NAT1 | ALDH1A1 1750/4885THRB 1809/4885MEN1 3887/4885 |
| US-20040034223-A1 | Amphiphilic molecular modules and constructs based thereon | ANXA6, THEM6, ANXA5 | ALDH1A1 4330/4885THRB 4639/4885MEN1 1323/4885 |
| US-20140057957-A1 | Novel Thiophene Inhibitors of S-Nitrosoglutathione Reductase | GSR, GRHPR, POR | ALDH1A1 346/4885THRB 1045/4885MEN1 4787/4885 |
| US-20040260085-A1 | Nanofilm and membrane compositions | CLPTM1, APMAP, PHOSPHO1 | ALDH1A1 4428/4885THRB 4535/4885MEN1 2215/4885 |
| US-20090318495-A1 | ETHENYL CARBOXAMIDE DERIVATIVES USEFUL AS MICROBIOCIDES | CD14, MSR1, ELANE | ALDH1A1 193/4885THRB 4556/4885MEN1 3370/4885 |
| US-20110136875-A1 | Pyrrole Inhibitors of S-Nitrosoglutathione Reductase | GSR, GRHPR, POR | ALDH1A1 452/4885THRB 2410/4885MEN1 4321/4885 |
| US-20220325025-A1 | CURABLE COMPOSITION AND STEREOLITHOGRAPHIC RESIN COMPOSITION COMPRISING SAME | ARL1, VCL, ARCN1 | ALDH1A1 1256/4885THRB 3833/4885MEN1 3773/4885 |
| US-20100087504-A1 | Use of Diindolylmethane (DIM) Compounds and Derivatives as Neuroprotective Agents | AIFM1, NLN, SNCA | ALDH1A1 1324/4885THRB 3311/4885MEN1 4042/4885 |
| US-20140329821-A1 | Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors | GSR, CBR1, POR | ALDH1A1 329/4885THRB 1767/4885MEN1 4669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.